Register for updates

 
 

Medicine & Health
RSS Feed
Slowing the Biological Clock
Monday, October 27, 2014 9:30:00 AM

TAU study finds neutralizing an immune system gene could improve the success of fertility treatments in women

Difficulty in conceiving a child is a major challenge for one in seven heterosexual couples in America, especially for those over the age of 35. Now a new discovery by researchers at Tel Aviv University and Chaim Sheba Medical Center at Tel Hashomer could boost the chances of conception in women undergoing in vitro fertilization (IVF) treatments.

Their new research reveals a linkage between the genes of the innate immune system — immunity with which human beings are born, rather than immunity they acquire during their lives — and ovarian longevity. The study, published recently in the Proceedings of the National Academy of Sciences, constituted the doctoral work of Dr. Shiri Uri-Belapolsky of TAU's Sackler School of Medicine. The research was led by Prof. Ruth Shalgi, of the Department of Cell and Developmental Biology at TAU's Sackler School of Medicine, Dr. Yehuda Kamari and Prof. Dror Harats of TAU's Sackler Faculty of Medicine and Sheba Medical Center, and Dr. Aviv Shaish of Sheba Medical Center.

According to research conducted on laboratory mice, the genetic deletion of the protein Interleukin-1 (IL-1), a key player in the innate immune system, could improve the number of eggs available for fertilization as well as improve the ovarian response to hormonal stimulation involved in IVF procedures. This could prove especially effective in women who initially respond poorly to hormonal treatment.

Neutralizing the risks

"We revealed a clear linkage between the genes of the innate immune system and female reproduction," said Dr. Uri-Belapolsky. "The results of our study, which point to neutralizing the effects of the IL-1 protein to slow down the natural processes that destroy the eggs, may set the basis for the development of new treatments, such as an IL-1 blockade that would raise the number of eggs recovered during an IVF cycle and reduce the amount of hormones injected into women undergoing the treatment."

The connection between IL-1 and fertility was discovered by accident in the course of research performed by the scientists on the role of IL-1 in atherosclerosis, the hardening of the arteries. In a surprise result of the research, the fertility lifespan of IL-1-deficient mice was found to be 20% longer than that of control wild-type mice.

Keeping the clock ticking

Female mammals, including humans, are born with a finite number of eggs and are subject to a biological clock that dictates the end of the reproductive lifespan at around 50 years of age. Over the past decade, a trend of postponing childbearing into advanced age has led to a corresponding upward trend in the number of IVF treatments. Inflammation has been reported to affect both IVF outcomes and the ovarian reserve adversely. "Identifying a possible culprit, such as Interleukin-1, may offer new insight into the mechanisms responsible for egg loss as well as practical interventions," the study reports.

"Our revelation is secured with a patent application, and naturally, further study in mice and in humans is required to examine this therapeutic opportunity," said Prof. Shalgi. "I believe we will take this research forward into human clinical trials. However, there is still research to be done before we can start these trials."




Latest News

2016 TLV Film Festival Celebrates 30 Years of Cinematic Imagination

Tel Aviv International Student Film Festival draws heavyweights, rising stars from local and international film industries.

Chinese Officials and Academics Visit TAU to Explore Food Safety

TAU partners with Peking University and OSI Group to host weeklong conference on food safety issues and solutions.

Tel Aviv University Awards UN Chief Highest Honor

UN Secretary-General Ban Ki-moon receives George S. Wise Medal for peace efforts and condemnation of anti-Semitism.

TAU and NYU Establish New Partnership for International Academic Collaboration

New collaborative research program will promote joint activities in chemistry, physics, material science, and engineering.

TAU Innovation Conference Spotlights Student Ingenuity

Budding innovators showcase inventions at gathering attended by investors, entrepreneurs from around the world.

Steve Tisch School of Film and Television Inaugurated

Visionary Oscar®-winning producer Steve Tisch cuts ribbon in a festive ceremony.

IDEAS Los Angeles Announces Acclaimed Israeli Actress Ayelet Zurer as Closing Keynote Speaker

Second annual conference hosted by AFTAU will explore Zurer's perspective on how digital advances are changing the movie and television business.

TAU Awards Honorary Doctorate to Oscar®-Winning Producer Steve Tisch

Philanthropist and filmmaker honored for vision and global influence in cinematic arts and for significant investment in university.

Genetic Testing Proves Bene Israel Community in India Has Jewish Roots

TAU–Cornell collaboration provides insight into unique community whose history is largely unknown.

New Study Shows We Are Bad Judges of Friendship

TAU researchers find inability to determine who our real friends are limits our powers of persuasion.

IDEAS Los Angeles Announces New Interactive Features for June Conference

Second annual conference hosted by AFTAU will include an outdoor demo lab, digital graffiti wall, virtual reality immersion and an international DJ.

TAU Student Film Wins Applause at Legendary Tribeca Film Festival

BBC calls Ben Hakim's The Operator "compelling."

Smartphone Users Are Redefining Privacy in Public Spaces

TAU study highlights how smartphone technology is leading to diminished privacy.

IDEAS Los Angeles Conference Announces Initial Speaker Lineup

Second annual conference to unite global industry leaders from Los Angeles, Silicon Valley and Tel Aviv on June 15-16 in Santa Monica.

contentSecondary
c

©2016 American Friends of Tel Aviv University